Marathon Pharmaceuticals Overview
- Status
-
Acquired/Merged
- Employees
-
51
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
4
- Investments
-
4
Marathon Pharmaceuticals General Information
Description
Developer of pharmaceuticals to treat rare diseases for high need populations. The company offers non-selective central nervous system depressants that are used as sedative hypnotics, pharmaceutical for the treatment of diarrhea and pharmaceutical for the short-term treatment of insomnia and used as preanesthetic before surgery.
Contact Information
Website
www.marathonpharma.comCorporate Office
- 1033 Skokie Boulevard
- Suite 600
- Northbrook, IL 60062
- United States
Corporate Office
- 1033 Skokie Boulevard
- Suite 600
- Northbrook, IL 60062
- United States
Marathon Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Marathon Pharmaceuticals Comparisons
Industry
Financing
Details
Marathon Pharmaceuticals Competitors (35)
One of Marathon Pharmaceuticals’s 35 competitors is GlaxoSmithKline Consumer Nigeria, a Corporation company based in Lagos, Nigeria.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GlaxoSmithKline Consumer Nigeria | Corporation | Lagos, Nigeria | ||||
| Corcept Therapeutics | Formerly VC-backed | Redwood City, CA | ||||
| BioMarin Pharmaceutical | Formerly PE-Backed | San Rafael, CA | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| Camurus | Corporation | Lund, Sweden |
Marathon Pharmaceuticals Patents
Marathon Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-5733874-A | Comprising hirudin and a water-soluble salt seleccted from calcium or magnesium chloride or magnesium sulfate | Inactive | 26-Jan-1994 | ||
| US-6436901-B1 | Composition comprising hirudin, potassium phosphate and sugar, prepared by forming isotonic solution of hirudin, dipotassium hydrogen phosphate, and selected sugar at specified hirudin concentration and freeze drying solution | Inactive | 26-Jan-1994 | ||
| US-5472938-A | Sustained release formulation containing water and calcium, magnesium or zinc ions in the form of water insoluble salts | Inactive | 18-Feb-1993 | ||
| US-6103515-A | Microorganism defective in preferential proteolytic acivities; for the therapy and prophylaxis of thrombosis, shock and coagulation defects; for use as diuretic, vasorelaxant and to control cardiovascular equlibrium | Inactive | 04-May-1988 | ||
| US-6410272-B1 | Generation of huridin compounds; obtain yeast cells, transform with vectors coding huridin compounds, isolate huridin compound | Inactive | 12-Dec-1985 | C07K14/815 |
Marathon Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Marathon Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Marathon Pharmaceuticals Investments & Acquisitions (4)
Marathon Pharmaceuticals’s most recent deal was a Early Stage VC with ReAlta Life Sciences for . The deal was made on 28-Apr-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ReAlta Life Sciences | 28-Apr-2021 | Early Stage VC | Drug Discovery | ||
| ReAlta Life Sciences | 21-Apr-2020 | Early Stage VC | Drug Discovery | ||
| Norphan Pharmaceuticals | 01-Jan-2013 | Merger/Acquisition | Pharmaceuticals | ||
| Bentus Laboratories | 01-Dec-2009 | Later Stage VC | Pharmaceuticals |
Marathon Pharmaceuticals Exits (1)
Marathon Pharmaceuticals’s most recent exit was on 01-Dec-2009 from Bentus Laboratories. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Bentus Laboratories | 01-Dec-2009 | Completed |
|
Marathon Pharmaceuticals FAQs
-
Where is Marathon Pharmaceuticals headquartered?
Marathon Pharmaceuticals is headquartered in Northbrook, IL.
-
What is the size of Marathon Pharmaceuticals?
Marathon Pharmaceuticals has 51 total employees.
-
What industry is Marathon Pharmaceuticals in?
Marathon Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Marathon Pharmaceuticals a private or public company?
Marathon Pharmaceuticals is a Private company.
-
What is Marathon Pharmaceuticals’s current revenue?
The current revenue for Marathon Pharmaceuticals is .
-
Who are Marathon Pharmaceuticals’s investors?
Ligand Pharmaceuticals and Valor Equity Partners have invested in Marathon Pharmaceuticals.
-
Who are Marathon Pharmaceuticals’s competitors?
GlaxoSmithKline Consumer Nigeria, Corcept Therapeutics, BioMarin Pharmaceutical, Pfizer Pakistan, and Camurus are some of the 35 competitors of Marathon Pharmaceuticals.
-
When was Marathon Pharmaceuticals acquired?
Marathon Pharmaceuticals was acquired on 01-Oct-2015.
-
Who acquired Marathon Pharmaceuticals?
Marathon Pharmaceuticals was acquired by CoPharma (United States).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
